Laurion Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.83M | Buy |
+8,395
| New | +$1.86M | 0.08% | 221 |
|
|
2024
Q3 | – | Sell |
-29,271
| Closed | -$5.02M | – | 280 |
|
|
2024
Q2 | $5.02M | Buy |
+29,271
| New | +$4.85M | 0.06% | 161 |
|
|
2024
Q1 | – | Sell |
-8,993
| Closed | -$1.39M | – | 512 |
|
|
2023
Q4 | $1.39M | Buy |
+8,993
| New | +$1.31M | 0.01% | 320 |
|
|
2023
Q2 | – | Sell |
-37,316
| Closed | -$5.47M | – | 585 |
|
|
2023
Q1 | $5.95M | Buy |
+37,316
| New | +$5.7M | 0.04% | 228 |
|
|
2022
Q2 | – | Sell |
-60,586
| Closed | -$9.26M | – | 457 |
|
|
2022
Q1 | $9.82M | Buy |
+60,586
| New | +$8.8M | 0.12% | 115 |
|
|
2021
Q4 | – | Sell |
-289,943
| Closed | -$34.2M | – | 533 |
|
|
2021
Q3 | $31.3M | Buy |
289,943
+259,493
| +852% | +$29.7M | 0.13% | 159 |
|
|
2021
Q2 | $3.43M | Buy |
+30,450
| New | +$3.43M | 0.02% | 316 |
|
|
2021
Q1 | – | Sell |
-155,225
| Closed | -$16.6M | – | 731 |
|
|
2020
Q4 | $16.6M | Buy |
+155,225
| New | +$14.9M | 0.13% | 142 |
|
|
2020
Q3 | – | Sell |
-12,500
| Closed | -$1.23M | – | 796 |
|
|
2020
Q2 | $1.23M | Buy |
+12,500
| New | +$1.1M | 0.01% | 379 |
|
|
2019
Q4 | – | Sell |
-1,000
| Closed | -$83K | – | 851 |
|
|
2019
Q3 | $76K | Sell |
1,000
-322,863
| -100% | -$22.1M | ﹤0.01% | 954 |
|
|
2019
Q2 | $23.6M | Buy |
+323,863
| New | +$25.5M | 0.23% | 106 |
|
|
2019
Q1 | – | Sell |
-17,341
| Closed | -$1.42M | – | 811 |
|
|
2018
Q4 | $1.6M | Sell |
17,341
-237,205
| -93% | -$20.9M | 0.03% | 471 |
|
|
2018
Q3 | $24.1M | Sell |
254,546
-75,769
| -23% | -$7.19M | 0.23% | 81 |
|
|
2018
Q2 | $30.6M | Sell |
330,315
-31,757
| -9% | -$3.1M | 0.25% | 93 |
|
|
2018
Q1 | $34.3M | Buy |
+362,072
| New | +$39.8M | 0.28% | 89 |
|
|
2017
Q4 | – | Sell |
-17,996
| Closed | -$1.7M | – | 1490 |
|
|
2017
Q3 | $1.6M | Sell |
17,996
-14,807
| -45% | -$1.13M | 0.01% | 837 |
|
|
2017
Q2 | $2.38M | Buy |
+32,803
| New | +$2.21M | 0.01% | 760 |
|
|
2017
Q1 | – | Sell |
-25,400
| Closed | -$1.6M | – | 1254 |
|
|
2016
Q4 | $1.59M | Buy |
+25,400
| New | +$1.55M | 0.02% | 629 |
|
|
2016
Q3 | – | Sell |
-799,335
| Closed | -$49.5M | – | 881 |
|
|
2016
Q2 | $49.5M | Buy |
799,335
+781,235
| +4,316% | +$47.6M | 0.77% | 34 |
|
|
2016
Q1 | $1.03M | Buy |
+18,100
| New | +$1.01M | 0.02% | 420 |
|
|
2015
Q3 | – | Sell |
-154,480
| Closed | -$10.1M | – | 714 |
|
|
2015
Q2 | $10.4M | Buy |
+154,480
| New | +$10.1M | 0.1% | 204 |
|
Other funds holding ABBV
VCM
VPM
Laurion Capital Management's ABBV Position: Q1 2026 in Review
Laurion Capital Management opened a new position in AbbVie (ABBV) in Q1 2026: 8,395 shares worth $1.83M. The stake represents 0.08% of the portfolio and ranks #221 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in ABBV as recently as Q2 2024.
Laurion Capital Management first reported a position in ABBV in Q2 2015 and has held it in 21 quarters since. The position peaked at $49.5M in Q2 2016. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Laurion Capital Management held 8,395 shares of AbbVie worth $1.83M as of Q1 2026.
- AbbVie was a new Laurion Capital Management position in Q1 2026.
- AbbVie made up 0.08% of Laurion Capital Management's portfolio in Q1 2026, its #221 holding.
- Laurion Capital Management first reported a position in AbbVie in Q2 2015 and has held it in 21 quarters since.
- Laurion Capital Management's AbbVie position peaked at $49.5M in Q2 2016.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.